ASTHMA AND ALLERGY CENTER, P.A. Home About Linda Cox Publications Directions Videos Privacy
Linda S. Cox, M.D., FAAAI, FACAAI ACP
Linda S. Cox, MD - (954) 771-0928 Home About Linda Cox Publications Directions Videos Privacy About Linda Cox About Linda Cox
Copyright (c) 2014 by Allergy & Asthma Center - Fort Lauderdale - Florida
CURRICULUM VITAE LINDA SUSAN COX, MD 5333 North Dixie Highway Suite 210 Ft. Lauderdale, Florida 33334 Telephone (954) 771-0928 Fax (954) 351-9397 Email: info@coxallergy.com Email: linda@coxallergy.com POST GRADUATE TRAINING: · National Jewish Hospital, Denver Colorado.  Fellow in Allergy and Immunology 1989 to 1991 · University of Miami, Jackson Memorial Hospital, Miami, Florida - Internal Medicine.      1985 to 1988 MEDICAL EDUCATION: · Northwestern University School of Medicine, Chicago, Illinois. Degree -Doctor of Medicine.     1985 GRADUATE EDUCATION: · Hahnemann Medical College of Graduate School - Department of Clinical Psychology,    Philadelphia, Pennsylvania. 1979 to 1980 · Harvard University Graduate School of Arts and Science Immunology Department              Cambridge, Massachusetts 1978 to 1979 UNDERGRADUATE EDUCATION: · Boston University College of Liberal Arts, Boston, Massachusetts. Bachelor of Arts, Cum Laude Honors -         1978 PROFESSIONAL WORK EXPERIENCE: · Private practice (solo) - Adult and Pediatric Allergy and Immunology – 5333 North Dixie Highway, Fort Lauderdale, Florida  1992 to present. · Imperial Point Medical Center (Employed by Coastal Physicians) part time  May 1997- August 1999 · Columbia Emergency Room (employed by Emergency Medical Services Association EMSA), Emergency Room Physician,  part- time - February 1995-May 1997  · Palmetto General Hospital (employed by Emergency Medical Services Association   EMSA), Emergency Room Physician, part- time - 1992 - October 1994.     · Private (partnership) - Allergy, Asthma and Clinical Immunology Center 1601 Biscayne Boulevard #226, Miami, Florida - 1991 to 1992. · Fitzsimmons Medical center (through national Emergency Services Association, NESA) Aurora, Colorado Emergency Room Physician, part-time - 1989 to 1991. · North Ridge Medical Center (through Emergency Medical Services Association, EMSA) Fort Lauderdale, Florida - Emergency room Physician, full-time 1988 to 1989, part-time-August 1994 to 1996. ACADEMIC APPOINTMENTS: § Affiliate Associate Professor of Clinical Biomedical Science Florida Atlantic University College of Medicine 2012-present § Associate Clinical Professor of Medicine, Nova Southeastern University College of Osteopathic Medicine Assistant Clinical Professor of Medicine : 2009 to present § Assistant Clinical Professor of Medicine, Nova Southeastern University College of Osteopathic Medicine 1998 to 2009 § Assistant Clinical Professor of Medicine University of Miami School of Medicine 1997-2001 PROFESSIONAL MEMBERSHIPS AND COMMITTEES: § American College of Physicians - Fellow § American College of Allergy, Asthma and Immunology - Fellow § American Academy of Allergy, Asthma and Immunology - Fellow American Academy of Allergy, Asthma and Immunology § President 2013-2014 § President-elect 2012-2013 § Secretary/Treasurer 2011-2012 § Board of Directors 2007-2011 § Executive Committee2010-2011 § Practice and Policy Division Chair 2007-2011 § Finance Committee 2010-2011 § Needs Assessment Committee Chair 2010-2011 § Member since 1990 § Fellow since 1999 § Media Link § Member 2002-to present § Nominating committee § Member 2002-03, 2012-2014 § Practice, Diagnostics and Therapeutics § Member 2001-2006 § Rhinosinusitis committee § Member 2006-present § Allergen standardization committee § Member 2007 to 2009 § Immunotherapy committee (current name Immunotherapy, Allergen Standardization & Allergy Diagnostics Committee) 1998 to present § Chair 2004 to 2009 § Vice-chair 2003 § Chair sub-committee Web initiative 2000 § Chair: sub-committee-practice parameters for allergy vaccines-2001 § Immunotherapy slide update committee-1999-2000, 2005 § Immunotherapy and skin test forms project 2001 to present § Asthma, Rhinitis and Other Respiratory Diseases Interest Section Secretary 2003 § Rhinitis, Sinusitis, and Ocular Disease Interest Section Chair 2005-7 American College of Allergy, Asthma and Immunology; Fellow § Immunotherapy and Allergy Diagnostics: § Chair 2005-2009 § Drug and Anaphylaxis Committee § Member 1996-97, 2011-2012 § Vice Chair 1997-98 § CME committee-2000-04, 2011 to present ACAAI/AAAAI Joint task Forces § Sublingual immunotherapy (co-chair) Joint Task Force 2004 to present § Omalizumab Joint Task Force (chair) § Specific IgE TestTask Force (chair) American Board Of Allergy And Immunology § Board of Directors: 2010-2016 § Recertification examination co-chair 2010-2012 § Immunotherapy measures development taskforce § Maintenance of Certification Committee 2010-present § Conjoint standards committee chair 2012 Broward Palm Beach Allergy Society: founder and primary coordinator of monthly CME program, president of Broward chapter: society founded in 2006, prior to this known as South Palm Beach Broward County Journal Club: 1998 to 2006 Broward County Medical Association-Member since 1993 § Chair Board of Trustees 2007-08 § Chair: Bylaws Committee 2004-5 § President 2003-04 § Board of Directors 1996-present § Public Affairs Committee § Member 1995 -1996 § Chair 2002-03 § Strategic Planning Committee § Member 1996 § Chair 2002-03 § Membership Development Committee chair 1997-2000 and 2002-3 § Women Physicians committee chair 1998 to 2001          Florida Allergy, Asthma and Immunology Society § President 2001-2002 § Practice Standard Committee 1993 § Education Committee 1993 Florida Medical Association § Board of Governors 2008-2010 § Practice Parameters Committee 1997-1998 § Membership committee 1998- to 2003  FDA Allergenic Products Advisory Committee  § Member 2007-2010 § Consultant 2010- present South Florida Caucus Advisory Council § Member 2006-present § Chair 2011-2012 Vision Broward: Health Care Task Force 2004 Wye River Group on Health Care: Roundtable discussions 2004 for Communities Shaping a Vision for America’s 21st Century Health and Healthcare. (Ft. Lauderdale- one of the 11 cities chosen to participate in this project) Editorial Boards: § Annals of Allergy Asthma and Immunology: Journal of the American College of Allergy, Asthma and Clinical Immunology  2004 to present § Allergy and Asthma Proceedings 2005 to present § Allergy, Asthma &Clinical Immunology: Journal of the Canadian Society of Allergy and Clinical Immunology § Current Allergy & Asthma Reports: Editor-Allergy Immunotherapy Sections 2012 to present Allergy and Asthma Proceedings: Section Editor Immunotherapy & Immunomodulators 2012-to present Current Treatment Options in Allergy: Section Editor Immunotherapy: 2013 to present   Journal of Allergy and Clinical Immunology: reviewer The Medical Letter: reviewer Clinical & Experimental Allergy: reviewer Holy Cross Medical Center      § Latex Allergy Committee                                 § Asthma Task Force Committee Joint Council of Allergy Asthma and Immunology § Membership Recruitment Committee 2003- present § Reimbursement and Coding Advisory Committee 2004- present § Sublingual Immunotherapy Joint Task Force Co-chair 2004-present § Membership Development  Task Force chair 2011 to present § STRIKE force (lobbying) 2010 -present Joint Task Force on Practice Parameters of the AAAAI, ACAAI and JCAAI § AAAAI representative 2006 –2012 (on leave of absence 2012-2014) World Allergy Organization · WAO Special Committee on Immunotherapy and Immunomodulators: Co-chair 2012-14 · Nominating Committee 2012 ACHA Advisory Board: alternative 2001-present ACHA Medical expert: 11/00 to present AMA  Physician Consortium on Practice Improvement (PBPI) Atopic Dermatitis Work Group:2010 BOARD CERTIFICATIONS: § American Board of Internal Medicine - 1988 § American Board of Allergy and Immunology - October 1991 re-certification August 2001, AWARDS/HONORS · 1998 Outstanding Mother of the Year 1998 -Healthy Mothers Healthy Babies Coalition of Broward County · 1998 Named as one of "The Best Doctors in America"   fourth listing Woodward/White, Inc. Aiken, S.C. · 1997, 1998, 1999 , 2001 Named one of "Best Physicians in the U.S."published in Consumer's Guide to Best Physicians in the U.S. Center for the Study of Services- Washington D.C. · 2001-02 named as One of South Florida’s Most High Regarded Physicians by Miami Metro and Castle Connolly Medical, Ltd · 2001: named in Florida Medical Business (Sept 4, 2001 Vol 14/Number 17) Outstanding Health Care Professionals Women in Medicine · 1997-2013: named in “America’s Top Physician” edition. Castle Connolly Medical, Ltd and/or  “Best Doctors in America” · 2005: Presidential Salute for Women in Medicine: Women Physicians in Leadership Positions Florida Medical Business (Sept 6, 2005, Volume 19, Number 17 · 2005: American Academy of Allergy, Asthma and Immunology Presidents Award for Outstanding Leadership as /chairman of the immunotherapy and allergy diagnostics committee. · 2007: American College of Allergy, Asthma and Immunology Distinguished Service Award · 2008 American College of Allergy, Asthma and Immunology Woman in Allergy Award · 2010:Florida Academy of Physician Assistants’ Physician Recognition Award · 2012: Women’s Involvement in the AAAAI Special Recognition Award PUBLICATIONS: Articles/Abstracts 1. Experience with Accelerated Immunotherapy Schedules Utilizing Multiple and Single Allergen Extracts in a Private Practice Setting. Abstract  ACAAI  1996 2. Borish, L, Dishuck J,Cox, L  Sezary syndrome with elevated serum IgE and hypereosinophilia: Role of dysregulated cytokine production. J Allergy Clin Immunol. 1993 Jul;92(1 Pt 1):123-31. 3. Chapter 41 entitled   Instruction and Consent Forms For Allergen Immunotherapy. Lockey Rf BS, Bousquet J (eds). Allergens and allergen immunotherapy. third ed. New York & Basel: MARCEL DEKKER, INC; 2004. 4. Cox, L Better documentation through standardized forms. What progress have we   made since the 1800s Allergy and Asthma Proc 24: 407-422, 2004 5. Carr, W, Martin, B,  Howard, B, Cox, L,  Borish,L  and the Immunotherapy Committee of the American Academy of Allergy, Asthma and Immunology Comparison of test devices for skin prick testing (J Allergy Clin Immunol 2005;116:341-6.) 6. Amin HS, Liss GM, Bernstein DI. and the Immunotherapy Committee of the American Academy of Allergy, Asthma and Immunology Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol. 2006 Jan;117(1):169-75 7. Cox, L Standardized allergen extracts: past, present and future Expert Review of Clinical Immunology, Nov 2005, Vol. 1, No. 4, Pages 579-588. 8. Cox L, Larenas-Linnemann D, Nolte H, Weldon D, Finegold I, Nelson H Sublingual Immunotherapy: A Comprehensive Review J Allergy Clin Immunol. 2006;117:1021-35 9. Cox, L Allergen immunotherapy: immunomodulatory treatment for allergic diseases Expert Review of Clinical Immunology, Jul 2006, Vol. 2, No. 4, Pages 533-546. 1. Cox, L Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol. 2006 Aug;97(2):126-37; quiz 137-40, 202. Review. 2. Cox L, Cohn JR. Duration of allergen immunotherapy in respiratory allergy: when is enough, enough? Ann Allergy Asthma Immunol 2007;98:416-26. 3. Cox L LJ, Nelson H, Lockey R. Allergen immunotherapy: A practice parameter second update. The Journal of Allergy and Clinical Immunology 2007;120:S25-S85 4. Cox L,Platts-Mills T, Finegold I et.al. ACAAI Joint Task Force Report on Omalizumab-Associated Anaphylaxis J Allergy Clin Immunol.2007;in press 5. Cox, L Sublingual Immunotherapy in PediatricAllergic Rhinitis and Asthma: Efficacy,Safety, and Practical ConsiderationsCurr Allergy Asthma Rep 2007;7:410-20 6. Larenas-Linnemann DE, Cox LS. Sublingual immunotherapy for asthma: need for high quality meta-analyses to prove the concept. Allergy 2007; 62:704-5; author reply 6-7. 7. Hankin CS, Cox L, Lang D, Levin A, Gross G, Eavy G, et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol 2008; 121:227-32. 8. Cox L. Sublingual immunotherapy and allergic rhinitis. Curr Allergy Asthma Rep 2008; 8:102-10. 9. Larenas-Linnemann D, Cox LS. European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol 2008; 100:137-45. 10. Cox L. Advantages and disadvantages of accelerated immunotherapy schedules. J Allergy Clin Immunol 2008; 122:432-4. 11. Cox L. Allergen immunotherapy and asthma: Efficacy, safety, and other considerations. Allergy Asthma Proc 2008;29:580-9. 12. Cox L, Lockey RF. Instructions and consent forms for subcutaneous allergen immunotherapy. Clin Allergy Immunol. 2008;21:499-525. 13. Cox L, Williams B, Sicherer S, et al. Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma and Immunology/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force. Ann Allergy Asthma Immunol 2008;101:580-92. 14. Casale TB, Canonica GW, Bousquet J, Cox L, et al. Recommendations for appropriate sublingual immunotherapy clinical trials. J Allergy Clin Immunol 2009;124:665-70. 15. Cox LS. How safe are the biologicals in treating asthma and rhinitis? Allergy Asthma Clin Immunol 2009;5:4. 16. Cox L, Jocobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol. 2009;103: 451–460. 17. Bousquet PJ, Cox LS, Durham SR, et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009;64 Suppl 91:1-59. 18. Hankin CS, Cox L, Lang D, et al. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study. Ann Allergy Asthma Immunol 2010;104:79-85. 19. Cox L, Larenas D, Lockey R, Passalacqua G. Speaking the Same Language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. . J Allergy Clin Immunol 125(3): 569-574, 574 e561-574 e567. 20. Cox L, Calderon MA. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe. Curr Med Res Opin 2010;26:2723-33. 21. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011;127:S1-55 22. Cox L, Compalati E, Canonica W. Will sublingual immunotherapy become an approved treatment method in the United States? Curr Allergy Asthma Rep 2011;11:4-6 23. Cox L, Lieberman P, Wallace D, Simons FE, Finegold I, Platts-Mills T, et al. American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up report. J Allergy Clin Immunol. 2011;128(1):210-2. 24. Cox L. Preface allergen immunotherapy: the first centenary and beyond. Immunol Allergy Clin North Am. 2011;31(2):xvii-x 25. Calabria CW, Cox L. Accelerated immunotherapy schedules and premedication. Immunol Allergy Clin North Am. 2011;31(2):251-63 26. Hankin CS, Cox L, Bronstone A. The health economics of allergen immunotherapy. Immunol Allergy Clin North Am. 2011;31(2):325-41 27. Cox L, Wallace D. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual. Immunol Allergy Clin North Am. 2011;31(3):561-99 28. Cox L, Esch RE, Corbett M, Hankin C, Nelson M, Plunkett G. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes. Ann Allergy Asthma Immunol. 2011;107(4):289-99 29. Cox L. Overview of Serological-Specific IgE Antibody Testing in Children. Current allergy and asthma reports. 2011;11(6):447-5 30. Calderon MA, Cox L, Casale TB, Moingeon P, Demoly P. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol 2012;129:929-34. 31. Canonica GW, Baena-Cagnani CE, Compalati E, et al. 100 Years of Immunotherapy: The Monaco Charter. Under the High Patronage of His Serene Highness Prince Albert II of Monaco. Int Arch Allergy Immunol 2012;160:346-9. 32. Cox L, Calderon M, Pfaar O. Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations. Immunotherapy 2012;4:601-16. 33. Cox L, Compalati E, Kundig T, Larche M. New directions in immunotherapy. Curr Allergy Asthma Rep. 2013;13(2):178-95. 34. Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013;131(5):1288-96 e3. 35. Calderon MA, Casale T, Cox L, et al. Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. Allergy 2013;68:825-8. 36. Passalacqua G, Baena-Cagnani CE, Bousquet J, et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol 2013;132:93-8. 37. Burks AW, Calderon MA, Casale T, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 2013;131:1288-96 e3. 38. Hankin CS, Cox L, Bronstone A, Wang Z. Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis. J Allergy Clin Immunol 2013;131:1084-91. 39. Cox L, Compalati E, Kundig T, Larche M. New directions in immunotherapy. Curr Allergy Asthma Rep 2013;13:178-95. 40. Canonica GW, Baena-Cagnani CE, Compalati E, et al. 100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. Int Arch Allergy Immunol 2013;160:346-9. 41. Cox L, Aaronson D, Casale TB, Honsinger R, Weber R. Allergy Immunotherapy Safety: Location Matters! Journal of Allergy and Clinical Immunology: In Practice. 2013;1(5):455-7. 42. Cox L. Sublingual immunotherapy for aeroallergens: Status in the United States. Allergy Asthma Proc. 2014;35(1):34-42 43.  Cox LS, Hankin C, Lockey R. Allergy immunotherapy adherence and delivery route: location does not matter. The journal of allergy and clinical immunology In practice. 2014;2(2):156-60 e2. 44. Calderon MA, Cox LS. Monoallergen Sublingual Immunotherapy Versus Multiallergen Subcutaneous Immunotherapy for Allergic Respiratory Diseases: A Debate During the AAAAI 2013 Annual Meeting in San Antonio, Texas. The journal of allergy and clinical immunology In practice. 2014;2(2):136-43. 45. Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. The World Allergy Organization journal. 2014;7(1):6. doi: 10.1186/1939-4551-7-6. 46.  Hankin C, Cox L,  Allergy immunotherapy (AIT): What is the evidence for cost saving? Current Opinion in Allergy & Clinical Immunology. 2014; in press 47. Huston, D. P., & Cox, L. S. (2014). EVidence-based evaluation for allergies to avoid inappropriate testing, diagnosis, and treatment. JAMA Intern Med. doi: 10.1001/jamainternmed.2014.1413